Regulatory EMA seeks input on virtual alternative to animal test PharmaphorumEMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.RegulatoryRead full story pharminent April 1, 2026 (Last updated: April 1, 2026) Pharmaphorum EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies. RegulatoryRead full story Post navigation Previous: Novo Sheds 400 at Embattled Manufacturing SiteNext: IO Shuts Down Following Regulatory Roadblocks Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026